Search

Search Results
Results 71 - 80 of 80 for Non-insulin dependent diabetes mellitus
  • Diamicron 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Diamicron 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Ardix Gliclazide 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Ardix Gliclazide 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Metformin History
    Health - 30 Sep 2021
    Metformin, a principle biguanide antihyperglycemic agent used agent, represents a mainstay of today's therapy in the treatment of non-insulin-dependent diabetes mellitus.
  • How Does Insulin Affect the Brain?
    Health - 27 Apr 2020
    Insulin is an important hormone that can be found in high concentrations in the human brain. This article investigates how insulin can affect the brain.
  • Nesina Met
    Drug - 23 Feb 2026
    Consumer Medicine Information (CMI) about Nesina Met intended for persons living in Australia.
  • Nesina
    Drug - 8 Dec 2025
    Consumer Medicine Information (CMI) about Nesina intended for persons living in Australia.
  • Comparative assessment of DCA Vantage and Atellica DCA HbA1c Dx assays
    Health - 22 Oct 2025
    Discover how the DCA Vantage and Atellica DCA HbA1c Dx assays measure up against the European reference laboratory method.
  • Risvan
    Drug - 10 Jul 2025
    Consumer Medicine Information (CMI) about Risvan intended for persons living in Australia.
  • Glyxambi
    Drug - 9 May 2025
    Consumer Medicine Information (CMI) about Glyxambi intended for persons living in Australia.
  • Jardiance
    Drug - 7 May 2025
    Consumer Medicine Information (CMI) about Jardiance intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback